Activated MKK3/MYC crosstalk impairs dabrafenib response in BRAFV600E colorectal cancer leading to resistance.
Biomed Pharmacother
; 167: 115480, 2023 Nov.
Article
in En
| MEDLINE
| ID: mdl-37713993
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Colorectal Neoplasms
/
Proto-Oncogene Proteins c-myc
/
MAP Kinase Kinase 3
Limits:
Humans
Language:
En
Journal:
Biomed Pharmacother
Year:
2023
Document type:
Article
Affiliation country:
Italia